Clinical Trial Update: Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating the safety of endobronchial mesenchymal stromal cells for chronic lung allograft dysfunction and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Allograft Dysfunction
• Lung Transplant Rejection

Drugs mentioned

• Endobronchial mesenchymal stromal cells (mesenchymal stromal cells)

Snippet

Sponsor: Instituto De Investigación Sanitaria Puerta De Hierro-Segovia De Arana | Conditions: Chronic Lung Disease, Lung Transplant Rejection | Phase 1 | Status: RECRUITING